Pakistan Listed Consumer Comp Sheet
Pakistan listed Consumer sector is currently trading at FY25 PE of 15.3x which is at a discount to its historical 10-year average of...
415 Views
Pakistan Pharmaceuticals - Deregulation Improved Sales and Margins
Pakistan listed pharmaceuticals sector's earnings were up by 83% YoY to Rs8.0bn in 3QFY25, driven by higher net sales, improved gross margins, and...
162 Views
Pakistan Pharmaceuticals: Pharma Sector Analysis FY24; Deregulation Improved Sales and Margins
Pakistan listed pharmaceuticals sector's earnings were up 70% YoY to Rs13.3bn in fiscal year 2024. This jump in profitability is...
762 Views
Pakistan Market Outlook | Strategy - Index to Reach 87k by Dec 2024, 106k by Jun 2025
We have revisited our target PE for Dec 2024 after incorporating Pakistan's successful completion of US$3bn stand-by agreement with IMF and...
605 Views
Pakistan Equity - Pharmaceuticals Sector; Court dismissed petition in favour of pharma companies
The Lahore High Court on April 02, 2024, disposed off the case in favour of the pharmaceutical industry and the stay order against deregulation...
341 Views